At Boston Children’s Hospital, our researchers are committed to developing new treatments for patients with end-stage renal disease, including more effective medications and new approaches to treating polycystic kidney disease.
Scientists in our Kidney Transplant Program are working to improve medications used after transplant, with the goal of improving transplant outcomes and reducing unwanted side effects and complications.
Additional information about our research is available on our research web site, including a list of transplant studies currently enrolling eligible patients.
